Product Description
| Brand | Beckman Coulter |
| Sample Type | Serum/ Plasma |
| Pack Size | 2 x 50T |
| CAT No. | 34250 |
Application | Infectious disease |
Beckman Coulter Access HBc IgM (CLIA) Reagent Kit is a high-performance Hepatitis B Core IgM Antibody (Anti-HBc IgM) chemiluminescent immunoassay reagent kit designed for the automated qualitative detection of Anti-HBc IgM antibodies in human serum or plasma. Utilizing advanced Chemiluminescent Immunoassay (CLIA) technology, the kit delivers rapid, highly sensitive, and reliable results with excellent analytical accuracy.
Advanced Diagnostic PerformanceRely on Beckman Coulter Access HBc IgM (CLIA) for highly sensitive and specific detection of Anti-HBc IgM antibodies, crucial for identifying acute or recent Hepatitis B infections. With its streamlined automation and CLIA technology, it delivers reliable and reproducible results in laboratory settings, supporting prompt clinical decisions.
Efficient and User-Friendly OperationEngineered for automatic and real-time operation, this reagent kit fits seamlessly into modern laboratories. Its portable design allows for easy integration into existing workflows, while minimal manual intervention ensures high throughput and reduced risk of error during testing.
Optimal Storage and HandlingTo maintain reagent efficacy, store the kit between 2 to 8 degrees Celsius. This temperature range preserves the integrity of the chemicals involved, assuring consistent and accurate performance throughout the product's shelf life.
FAQ's of Beckman Coulter Access HBc IgM (CLIA):
Q: How does the Beckman Coulter Access HBc IgM (CLIA) kit detect acute Hepatitis B infections?
A: The kit identifies IgM antibodies to the Hepatitis B core antigen (Anti-HBc IgM) using Chemiluminescence Immunoassay (CLIA) technology. The presence of these antibodies indicates an acute or recent Hepatitis B infection, enabling accurate diagnosis.
Q: What is the primary advantage of using this CLIA reagent kit in the laboratory?
A: The main benefit is its automated, real-time operation that ensures rapid, reliable, and reproducible results. With minimal manual handling required, laboratories can improve workflow efficiency and maintain high testing accuracy.
Q: When should this test be administered to a patient?
A: This test is typically used when acute Hepatitis B infection or recent exposure is suspected, based on clinical symptoms, elevated liver enzymes, or during hepatitis screening programs, to support early and precise diagnosis.
Q: Where can the Beckman Coulter Access HBc IgM (CLIA) reagent kit be utilized?
A: It is designed for use in laboratory environments across hospitals, clinics, and diagnostic centers. Its portability facilitates adoption in diverse healthcare settings throughout India.
Q: What is the process for using this reagent kit?
A: Place the patient's sample and reagent kit components in the compatible analyzer. The automated system processes the sample and provides qualitative results indicating the presence or absence of Anti-HBc IgM antibodies.
Q: How should the kit be stored and handled?
A: Store the reagent kit at temperatures between 2 to 8C to preserve reagent stability and reliability. Proper storage ensures the kit delivers accurate results throughout its usage period.